RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
RT SocSurgOnc RT AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. https://t.co/mlwtiIdpJh McMastersKelly SocSurgOnc https://t.co/810k9iu2xz
RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
RT @AnnSurgOncol: FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancrea…
FREELY AVAILAbLE: Differences in Treatment and Outcome of #PancreaticAdenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. https://t.co/DF0pTgJV8W @McMastersKelly @SocSurgOnc https://t.co/6IzMxzwslZ